Form 4: MapLight CMO Erin Foff Sells Shares for Tax Obligations

Chief Medical Officer Erin Foff sold 3,213 shares of MapLight Therapeutics to cover statutory tax withholding obligations.

Summary

• Erin Foff, Chief Medical Officer of MapLight Therapeutics, Inc. (MPLT), executed a series of stock sales on April 15 and April 16, 2026.
• A total of 3,213 shares of Voting Common Stock were sold across three transactions.
• The sales were conducted to satisfy statutory tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, the reporting person retains beneficial ownership of 400,777 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely for tax compliance purposes and does not indicate a lack of confidence in the company.

Positives

• The transactions were non-discretionary, specifically executed to satisfy tax obligations associated with equity vesting.

Negatives

• Reduction in the direct equity stake held by a key executive.

Risks

• None identified; the filing relates to routine tax-related equity transactions.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory disclosure for executive equity management and does not reflect a change in corporate strategy or operational performance.

Comparison to Industry Standards

• The sale of shares to cover tax withholding upon RSU vesting is a standard practice for executives in the biotechnology sector.
• The transaction volume is consistent with typical executive tax-planning activities.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was for tax compliance.

Key Dates

Keywords

MPLT, MapLight Therapeutics, Insider Trading, Form 4, Chief Medical Officer, Equity Vesting